{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:49:01Z","timestamp":1782226141534,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Hereditary polyneuropathies are rare heterogeneous neurological disorders that cause progressive muscle weakness and disability. As new therapies emerge, sensitive imaging biomarkers to monitor disease progression are essential. This exploratory longitudinal study evaluated MRI with focus on the lower limbs and high-resolution ultrasound (HRUS) at two points over the period of 4.75 years in genetically confirmed patients, and compared imaging with clinical and electrophysiological findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fourteen patients (CMT1A, CMT1X, CMT1B, CMT1C, CMT2, and hereditary myoneuropathy) underwent standardized clinical examinations, including Charcot-Marie-Tooth Examination Score version 2 (CMTESv2), Medical Research Counsil muscle strength, and sensory testing. Nerve conduction studies (NCS) were performed on upper limb nerves. MRI of lower limbs evaluated muscle volume, normalized T1w signal intensity (nSI), and proton density fat fraction (PDFF). HRUS was used to assess nerve cross-sectional areas, the ultrasound pattern sum score (UPSS), and muscle echogenicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over the observation interval, patients showed a significant increase in CMTESv2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0031), especially in motor symptoms (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0012). MRI-derived muscle volumes did not change; however, nSI significantly increased in gastrocnemius lateralis muscles (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0023), indicating progressive fat infiltration. UPSS increased in demyelinating polyneuropathies (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0299) and was inversely correlated with nerve conduction velocities of the median (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0413) and ulnar nerves (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0064).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>Over this 5-year interval, our cohort showed clinical disease progression, which was not reflected by NCS and MRI volumetry. In contrast, MRI-derived nSI correlated with PDFF and captured progressive muscle fat replacement, correlating with declining muscle strength. UPSS showed longitudinal progression in demyelinating neuropathies. PDFF and UPSS are promising biomarkers and may support outcome evaluation in future clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42466-026-00508-1","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:51:06Z","timestamp":1782222666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal five-year follow-up by muscle MRI and high-resolution nerve ultrasound in hereditary neuropathies"],"prefix":"10.1186","volume":"8","author":[{"given":"Kim L.","family":"Vockert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike S.","family":"Kirschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Kuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Nebelung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lemainque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5320-9807","authenticated-orcid":false,"given":"Maike F.","family":"Dohrn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"508_CR1","doi-asserted-by":"publisher","unstructured":"Timmerman, V., Strickland, A. V., & Zuchner, S. (2014). Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success. Genes (Basel). Jan 22. ;5(1):13\u201332. https:\/\/doi.org\/10.3390\/genes5010013","DOI":"10.3390\/genes5010013"},{"issue":"3","key":"508_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/practneurol-2015-001095","volume":"15","author":"AM Rossor","year":"2015","unstructured":"Rossor, A. M., Evans, M. R., & Reilly, M. M. (2015). A practical approach to the genetic neuropathies. Pract Neurol Jun, 15(3), 187\u2013198. https:\/\/doi.org\/10.1136\/practneurol-2015-001095","journal-title":"Pract Neurol Jun"},{"issue":"8","key":"508_CR3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","volume":"86","author":"V Fridman","year":"2015","unstructured":"Fridman, V., Bundy, B., Reilly, M. M., et al. (2015). CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry Aug, 86(8), 873\u2013878. https:\/\/doi.org\/10.1136\/jnnp-2014-308826","journal-title":"J Neurol Neurosurg Psychiatry Aug"},{"issue":"11","key":"508_CR4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1136\/jnnp-2024-333436","volume":"16","author":"JM Parmar","year":"2024","unstructured":"Parmar, J. M., Laing, N. G., Kennerson, M. L., & Ravenscroft, G. (2024). Genetics of inherited peripheral neuropathies and the next frontier: looking backwards to progress forwards. J Neurol Neurosurg Psychiatry Oct, 16(11), 992\u20131001. https:\/\/doi.org\/10.1136\/jnnp-2024-333436","journal-title":"J Neurol Neurosurg Psychiatry Oct"},{"issue":"1","key":"508_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s13023-021-02040-8","volume":"16","author":"S Attarian","year":"2021","unstructured":"Attarian, S., Young, P., Brannagan, T. H., et al. (2021). A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A. Orphanet J Rare Dis Oct, 16(1), 433. https:\/\/doi.org\/10.1186\/s13023-021-02040-8","journal-title":"Orphanet J Rare Dis Oct"},{"issue":"5","key":"508_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41588-020-0615-4","volume":"52","author":"A Cortese","year":"2020","unstructured":"Cortese, A., Zhu, Y., Rebelo, A. P., et al. (2020). Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes. Nat Genet May, 52(5), 473\u2013481. https:\/\/doi.org\/10.1038\/s41588-020-0615-4","journal-title":"Nat Genet May"},{"issue":"10","key":"508_CR7","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00415-017-8547-3","volume":"264","author":"J Burakiewicz","year":"2017","unstructured":"Burakiewicz, J., Sinclair, C. D. J., Fischer, D., Walter, G. A., Kan, H. E., & Hollingsworth, K. G. (2017). Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy. J Neurol Oct, 264(10), 2053\u20132067. https:\/\/doi.org\/10.1007\/s00415-017-8547-3","journal-title":"J Neurol Oct"},{"key":"508_CR8","doi-asserted-by":"publisher","unstructured":"B\u00e4hr, F. S., Gess, B., Muller, M., et al. (2021). Semi-Automatic MRI Muscle Volumetry to Diagnose and Monitor Hereditary and Acquired Polyneuropathies. Brain Sci Feb, 6(2). https:\/\/doi.org\/10.3390\/brainsci11020202","DOI":"10.3390\/brainsci11020202"},{"issue":"1","key":"508_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00415-022-11336-z","volume":"270","author":"E Vegezzi","year":"2023","unstructured":"Vegezzi, E., Cortese, A., Bergsland, N., et al. (2023). Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study. J Neurol Jan, 270(1), 328\u2013339. https:\/\/doi.org\/10.1007\/s00415-022-11336-z","journal-title":"J Neurol Jan"},{"issue":"10","key":"508_CR10","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1111\/ene.15970","volume":"30","author":"C Durelle","year":"2023","unstructured":"Durelle, C., Delmont, E., Michel, C., et al. (2023). Quantification of muscle involvement in familial amyloid polyneuropathy using MRI. Eur J Neurol Oct, 30(10), 3286\u20133295. https:\/\/doi.org\/10.1111\/ene.15970","journal-title":"Eur J Neurol Oct"},{"issue":"14","key":"508_CR11","doi-asserted-by":"publisher","first-page":"e1480","DOI":"10.1212\/WNL.0000000000009013","volume":"7","author":"J Bas","year":"2020","unstructured":"Bas, J., Ogier, A. C., Le Troter, A., et al. (2020). Fat fraction distribution in lower limb muscles of patients with CMT1A: A quantitative MRI study. Neurology Apr, 7(14), e1480\u2013e1487. https:\/\/doi.org\/10.1212\/WNL.0000000000009013","journal-title":"Neurology Apr"},{"issue":"4","key":"508_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/acn3.52314","volume":"12","author":"MRB Evans","year":"2025","unstructured":"Evans, M. R. B., Salhab, H. A., Sinclair, C. D. J., et al. (2025). Twelve-month change in quantitative MRI calf muscle fat fraction in CMT1A predicts clinical change over 4 years. Ann Clin Transl Neurol Apr, 12(4), 756\u2013767. https:\/\/doi.org\/10.1002\/acn3.52314","journal-title":"Ann Clin Transl Neurol Apr"},{"key":"508_CR13","doi-asserted-by":"publisher","unstructured":"Doherty, C. M., Morrow, J. M., Zuccarino, R., et al. (Mar 2024). Lower limb muscle MRI fat fraction is a responsive outcome measure in CMT X1, 1B and 2A. Annals Of Clinical And Translational Neurology, 11(3), 607\u2013617. https:\/\/doi.org\/10.1002\/acn3.51979","DOI":"10.1002\/acn3.51979"},{"key":"508_CR14","doi-asserted-by":"publisher","unstructured":"Ravid, B., Krivitski, D., Nechushtan, E., & Abraham, A. (2025). Sonographic Muscle Thickness Assessment Correlates With Disease Burden and Progression in Charcot-Marie-Tooth 1A Disease. J Clin Neurophysiol May, 27. https:\/\/doi.org\/10.1097\/WNP.0000000000001172","DOI":"10.1097\/WNP.0000000000001172"},{"issue":"4","key":"508_CR15","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s13311-021-01141-3","volume":"18","author":"N Winter","year":"2021","unstructured":"Winter, N., Vittore, D., Gess, B., Schulz, J. B., Grimm, A., & Dohrn, M. F. (2021). New Keys to Early Diagnosis: Muscle Echogenicity, Nerve Ultrasound Patterns, Electrodiagnostic, and Clinical Parameters in 150 Patients with Hereditary Polyneuropathies. Neurotherapeutics Oct, 18(4), 2425\u20132435. https:\/\/doi.org\/10.1007\/s13311-021-01141-3","journal-title":"Neurotherapeutics Oct"},{"key":"508_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s42466-020-00064-2","volume":"2","author":"HC Lehmann","year":"2020","unstructured":"Lehmann, H. C., Wunderlich, G., Fink, G. R., & Sommer, C. (2020). Diagnosis of peripheral neuropathy. Neurol Res Pract, 2, 20. https:\/\/doi.org\/10.1186\/s42466-020-00064-2","journal-title":"Neurol Res Pract"},{"issue":"11","key":"508_CR17","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s00415-018-9037-y","volume":"265","author":"K Mul","year":"2018","unstructured":"Mul, K., Horlings, C. G. C., Vincenten, S. C. C., Voermans, N. C., van Engelen, B. G. M., & van Alfen, N. (2018). Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers. J Neurol Nov, 265(11), 2646\u20132655. https:\/\/doi.org\/10.1007\/s00415-018-9037-y","journal-title":"J Neurol Nov"},{"key":"508_CR18","doi-asserted-by":"publisher","unstructured":"Compston, A. (2010). Aids to the investigation of peripheral nerve injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty\u2019s Stationery Office: 1942; p. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O\u2019Brien for the Guarantors of Brain. Saunders Elsevier: ; p. [8] 64 and 94 Figures. Brain. Oct 2010;133(10):2838-44. https:\/\/doi.org\/10.1093\/brain\/awq270","DOI":"10.1093\/brain\/awq270"},{"issue":"3","key":"508_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1529-8027.2011.00350.x","volume":"16","author":"SM Murphy","year":"2011","unstructured":"Murphy, S. M., Herrmann, D. N., McDermott, M. P., et al. (2011). Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. J Peripher Nerv Syst Sep, 16(3), 191\u2013198. https:\/\/doi.org\/10.1111\/j.1529-8027.2011.00350.x","journal-title":"J Peripher Nerv Syst Sep"},{"issue":"1","key":"508_CR20","doi-asserted-by":"publisher","first-page":"e0169878","DOI":"10.1371\/journal.pone.0169878","volume":"12","author":"W Wang","year":"2017","unstructured":"Wang, W., Guedj, M., Bertrand, V., et al. (2017). A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients. PLoS One, 12(1), e0169878. https:\/\/doi.org\/10.1371\/journal.pone.0169878","journal-title":"PLoS One"},{"issue":"3","key":"508_CR21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/mrm.26485","volume":"78","author":"S Ruschke","year":"2017","unstructured":"Ruschke, S., Eggers, H., Kooijman, H., et al. (2017). Correction of phase errors in quantitative water-fat imaging using a monopolar time-interleaved multi-echo gradient echo sequence. Magn Reson Med Sep, 78(3), 984\u2013996. https:\/\/doi.org\/10.1002\/mrm.26485","journal-title":"Magn Reson Med Sep"},{"key":"508_CR22","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1109\/EMBC.2016.7591443","volume":"2016","author":"PA Yushkevich","year":"2016","unstructured":"Yushkevich, P. A., Yang, G., & Gerig, G. (2016). ITK-SNAP: An interactive tool for semi-automatic segmentation of multi-modality biomedical images. Annu Int Conf IEEE Eng Med Biol Soc Aug, 2016, 3342\u20133345. https:\/\/doi.org\/10.1109\/EMBC.2016.7591443","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc Aug"},{"issue":"1","key":"508_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12021-018-9385-x","volume":"17","author":"PA Yushkevich","year":"2019","unstructured":"Yushkevich, P. A., Pashchinskiy, A., Oguz, I., et al. (2019). User-Guided Segmentation of Multi-modality Medical Imaging Datasets with ITK-SNAP. Neuroinformatics Jan, 17(1), 83\u2013102. https:\/\/doi.org\/10.1007\/s12021-018-9385-x","journal-title":"Neuroinformatics Jan"},{"issue":"2","key":"508_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11282-019-00397-y","volume":"36","author":"AF Gomes","year":"2020","unstructured":"Gomes, A. F., Brasil, D. M., Silva, A. I. V., Freitas, D. Q., Haiter-Neto, F., & Groppo, F. C. (2020). Accuracy of ITK-SNAP software for 3D analysis of a non-regular topography structure. Oral Radiol Apr, 36(2), 183\u2013189. https:\/\/doi.org\/10.1007\/s11282-019-00397-y","journal-title":"Oral Radiol Apr"},{"issue":"2","key":"508_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00415-015-7953-7","volume":"263","author":"A Grimm","year":"2016","unstructured":"Grimm, A., Rasenack, M., Athanasopoulou, I. M., et al. (2016). The modified ultrasound pattern sum score mUPSS as additional diagnostic tool for genetically distinct hereditary neuropathies. J Neurol Feb, 263(2), 221\u2013230. https:\/\/doi.org\/10.1007\/s00415-015-7953-7","journal-title":"J Neurol Feb"},{"issue":"4","key":"508_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/mus.27830","volume":"68","author":"EA Tawfik","year":"2023","unstructured":"Tawfik, E. A., Cartwright, M. S., van Alfen, N., et al. (2023). Neuromuscular ultrasound standardized scanning techniques and protocols: Expert panel recommendations. Muscle Nerve Oct, 68(4), 375\u2013379. https:\/\/doi.org\/10.1002\/mus.27830","journal-title":"Muscle Nerve Oct"},{"issue":"1","key":"508_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/mus.24274","volume":"51","author":"EJ Jelsing","year":"2015","unstructured":"Jelsing, E. J., Presley, J. C., Maida, E., Hangiandreou, N. J., & Smith, J. (2015). The effect of magnification on sonographically measured nerve cross-sectional area. Muscle Nerve Jan, 51(1), 30\u201334. https:\/\/doi.org\/10.1002\/mus.24274","journal-title":"Muscle Nerve Jan"},{"issue":"5","key":"508_CR28","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/s0022-3476(82)80286-2","volume":"101","author":"JZ Heckmatt","year":"1982","unstructured":"Heckmatt, J. Z., Leeman, S., & Dubowitz, V. (1982). Ultrasound imaging in the diagnosis of muscle disease. J Pediatr Nov, 101(5), 656\u2013660. https:\/\/doi.org\/10.1016\/s0022-3476(82)80286-2","journal-title":"J Pediatr Nov"},{"key":"508_CR29","doi-asserted-by":"publisher","unstructured":"Schlaffke, L., Rehmann, R., Guttsches, A. K., et al. (2024). Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI. J Clin Med Mar, 28(7). https:\/\/doi.org\/10.3390\/jcm13071958","DOI":"10.3390\/jcm13071958"},{"issue":"1","key":"508_CR30","doi-asserted-by":"publisher","first-page":"37993","DOI":"10.1038\/s41598-025-21901-x","volume":"30","author":"JH Kim","year":"2025","unstructured":"Kim, J. H., Kim, H. S., Lee, J. H., et al. (2025). Evaluation of normalized T1 signal intensity obtained using an automated segmentation model in lower leg MRI as a potential imaging biomarker in Charcot-Marie-Tooth disease type 1 A. Sci Rep Oct, 30(1), 37993. https:\/\/doi.org\/10.1038\/s41598-025-21901-x","journal-title":"Sci Rep Oct"},{"issue":"1","key":"508_CR31","doi-asserted-by":"publisher","first-page":"e70456","DOI":"10.1111\/ene.70456","volume":"33","author":"M Paya","year":"2026","unstructured":"Paya, M., Portela, S., Sivera, R., et al. (2026). Muscle MRI Contributes to the Differential Diagnosis Between Distal Myopathies and Distal Hereditary Motor Neuropathies. Eur J Neurol Jan, 33(1), e70456. https:\/\/doi.org\/10.1111\/ene.70456","journal-title":"Eur J Neurol Jan"},{"issue":"10","key":"508_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.nmd.2023.08.010","volume":"33","author":"D Esteller","year":"2023","unstructured":"Esteller, D., Morrow, J., Alonso-Perez, J., et al. (2023). Muscle magnetic resonance imaging of a large cohort of distal hereditary motor neuropathies reveals characteristic features useful for diagnosis. Neuromuscul Disord Oct, 33(10), 744\u2013753. https:\/\/doi.org\/10.1016\/j.nmd.2023.08.010","journal-title":"Neuromuscul Disord Oct"},{"issue":"1","key":"508_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/acn3.50953","volume":"7","author":"M Pridmore","year":"2020","unstructured":"Pridmore, M., Castoro, R., McCollum, M. S., Kang, H., Li, J., & Dortch, R. (2020). Length-dependent MRI of hereditary neuropathy with liability to pressure palsies. Ann Clin Transl Neurol Jan, 7(1), 15\u201325. https:\/\/doi.org\/10.1002\/acn3.50953","journal-title":"Ann Clin Transl Neurol Jan"},{"issue":"12","key":"508_CR34","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.1007\/s00415-023-11862-4","volume":"270","author":"D Esteller","year":"2023","unstructured":"Esteller, D., Schiava, M., Verdu-Diaz, J., et al. (2023). Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis. J Neurol Dec, 270(12), 5849\u20135865. https:\/\/doi.org\/10.1007\/s00415-023-11862-4","journal-title":"J Neurol Dec"},{"issue":"2\u20133","key":"508_CR35","first-page":"95","volume":"34","author":"J Diaz-Manera","year":"2015","unstructured":"Diaz-Manera, J., Llauger, J., Gallardo, E., & Illa, I. (2015). Muscle MRI in muscular dystrophies. Acta Myol Dec, 34(2\u20133), 95\u2013108.","journal-title":"Acta Myol Dec"},{"issue":"4","key":"508_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/jnnp-2014-308211","volume":"86","author":"Y Noto","year":"2015","unstructured":"Noto, Y., Shiga, K., Tsuji, Y., et al. (2015). Nerve ultrasound depicts peripheral nerve enlargement in patients with genetically distinct Charcot-Marie-Tooth disease. J Neurol Neurosurg Psychiatry Apr, 86(4), 378\u2013384. https:\/\/doi.org\/10.1136\/jnnp-2014-308211","journal-title":"J Neurol Neurosurg Psychiatry Apr"},{"issue":"1","key":"508_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mus.26724","volume":"61","author":"Y Pan","year":"2020","unstructured":"Pan, Y., Kafaie, J., & Thomas, F. P. (2020). Longitudinal 16-year study of dominant intermediate CMT type C neuropathy. Muscle Nerve Jan, 61(1), 111\u2013115. https:\/\/doi.org\/10.1002\/mus.26724","journal-title":"Muscle Nerve Jan"},{"issue":"10","key":"508_CR38","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/ene.13079","volume":"23","author":"F Manganelli","year":"2016","unstructured":"Manganelli, F., Pisciotta, C., Reilly, M. M., et al. (2016). Nerve conduction velocity in CMT1A: what else can we tell? Eur J Neurol Oct, 23(10), 1566\u20131571. https:\/\/doi.org\/10.1111\/ene.13079","journal-title":"Eur J Neurol Oct"},{"issue":"6","key":"508_CR39","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/mus.27068","volume":"62","author":"Y Kojima","year":"2020","unstructured":"Kojima, Y., Noto, Y. I., Tsuji, Y., et al. (2020). Charcot-Marie-Tooth disease type 1A: Longitudinal change in nerve ultrasound parameters. Muscle Nerve Dec, 62(6), 722\u2013727. https:\/\/doi.org\/10.1002\/mus.27068","journal-title":"Muscle Nerve Dec"},{"issue":"1","key":"508_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clinph.2016.11.010","volume":"128","author":"N Shahrizaila","year":"2017","unstructured":"Shahrizaila, N., Noto, Y., Simon, N. G., et al. (2017). Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy. Clin Neurophysiol Jan, 128(1), 227\u2013232. https:\/\/doi.org\/10.1016\/j.clinph.2016.11.010","journal-title":"Clin Neurophysiol Jan"},{"issue":"1","key":"508_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s42466-023-00230-2","volume":"26","author":"JM Pardal-Fernandez","year":"2023","unstructured":"Pardal-Fernandez, J. M., Diaz-Maroto, I., Segura, T., & de Cabo, C. (2023). Ulnar nerve thickness at the elbow on longitudinal ultrasound view in control subjects. Neurol Res Pract Jan, 26(1), 4. https:\/\/doi.org\/10.1186\/s42466-023-00230-2","journal-title":"Neurol Res Pract Jan"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00508-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00508-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00508-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:51:08Z","timestamp":1782222668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-026-00508-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00508-1","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the local institutional review board (EK215-18, CTC-A22-338).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MFD has received a research grant byPfizer Pharmaceuticals (ASPIRE 2018). She further received financial reimbursement for consulting and advisory board activities and travel support to attend scientific meetings by AkceaTherapeuticals, Alnylam Pharmaceuticals, Applied Therapeutics, Astra Zeneca, Pfizer Pharmaceuticals, and Swedish Orphan Biovitrum AB.NWreceived financial reimbursement for consulting activities and travel support to attend scientific meetings by argenx Germany GmbH, Canon Medical Systems, Pfizer Pharmaceuticals.The remaining authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}